Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
UniSUC has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top External Urine Management Device Solutions Provider - 2024,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Maciej Witkos, Md, Msc, Faaem, Chief Medical Officer; Allan Pepito, Founder And Chief Operating Officer, Qae; Alvin Pepito, Founder And Chief Executive Officer, Rn, Phn.



![]()
Our device produces less than 10 ounces of waste material per use, compared to the 50 to 60 ounces that result from diaper use



Company
UniSUC
Management
Maciej Witkos, Md, Msc, Faaem, Chief Medical Officer; Allan Pepito, Founder And Chief Operating Officer, Qae; Alvin Pepito, Founder And Chief Executive Officer, Rn, Phn
Description
AlPep is a new, innovative and agile medical device company that has devised a novel urinary catheter called UniSUC. It is a non-invasive, unisex, external catheter designed for adult incontinence management to be used by people who are bed-bound or have limited mobility.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
